Medical Devices Startups

Lumencor develops photonics solutions and LED lighting technologies. The company serves research, medical, and industrial markets with specialized light sources.

1 investor

Lumenis develops and commercializes energy-based medical devices for the aesthetics and vision markets, serving healthcare professionals worldwide. The company holds over 330 patents and numerous FDA clearances, with an installed base of more than 80,000 systems across over 100 countries.

1 investor

1 investor

Luminist Labs provided a non-invasive test to identify and assess the progression of liver fibrosis and NASH in patients. The company was acquired by DiscernDx in 2020.

1 investor

Luminoah is a medical technology company developing a connected enteral nutrition (tube feeding) system that combines a compact smart pump with a mobile app to track feeding data. Its products serve individuals who rely on tube feeding, along with their caregivers and clinicians.

1 investor

Lumius develops a 3D ultrasound device designed to provide fast, smart, and accessible imaging capabilities. The device functions as a 3D camera for internal body visualization, serving the medical imaging market.

1 investor

Lumos Diagnostics develops rapid point-of-care diagnostic tests and digital reader platforms for healthcare professionals, targeting infectious and inflammatory diseases. The company offers both customized assay development services and proprietary branded diagnostic solutions.

1 investor

Lumov Health designs and sells orthopedic support products such as knee braces, insoles, lumbo sacral belts, and compression stockings, developed with orthopedic doctors and tailored to Indian anatomy and weather conditions.

1 investor

LUNAC Therapeutics develops first-in-class oral and intravenous anticoagulants targeting activated Factor XII to treat and prevent thrombotic events with reduced bleeding risk. The company focuses on cardiovascular and blood coagulation therapies for patients requiring anticoagulation.

1 investor

Lunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.

1 investor

Lunaphore provides spatial biology technology and solutions that enable researchers to integrate spatial analysis into laboratory workflows. The company offers a scalable, precision platform designed to make spatial biology research accessible and mainstream across diverse lab environments.

1 investor

Lura Health develops a wearable saliva-based health monitor that integrates micro sensors into dental hardware such as aligners or attaches to a tooth to continually track biomarkers like glucose and electrolytes. The device sends data to a smartphone app and to doctors to support monitoring of chronic conditions such as diabetes and hypertension.

1 investor

Cynosure Lutronic develops laser and radiofrequency (RF) medical devices for aesthetic and gynecologic treatments, including its XERF RF treatment. Its products are sold to practitioners, physicians, and aesthetic practice owners to expand their treatment offerings.

1 investor

LUX MED operates a network of private medical facilities in Poland, offering diagnostic imaging (MRI, CT, mammography, ultrasound, X-ray), laboratory testing, specialist physician consultations, and optical salons. It serves patients seeking outpatient healthcare and provides urgent medical assistance around the clock.

1 investor

LuxCreo offers an in-house 3D printing ecosystem for dental practices, combining printers, curing and washing hardware, resins, and software to produce direct-print clear aligners and other dental devices. Its workflow removes the model and thermoforming steps and includes an FDA Class II 510(k)-cleared direct-print aligner process for orthodontics, prosthodontics, and restorative dentistry.

1 investor

LVIS provides a cloud-based EEG software platform that enables hospitals to access and collaborate on neurological diagnostic data from multiple EEG systems through a single vendor-agnostic interface, reducing reliance on proprietary local software and IT infrastructure.

1 investor

LXE Hearing is the parent company of hearing-technology brands Eargo, Lexie Hearing, and hearX, offering direct-to-consumer and over-the-counter hearing aids plus tools for detecting and diagnosing hearing loss. The company has begun winding down its US operations.

1 investor

Lydus Medical develops surgical devices for anastomosis procedures in microsurgery, combining clinical insight with engineering to make these operations faster and more reliable. The company was founded within Sanara Ventures based on a clinical need identified in the microsurgery operating room.

1 investor

LyGenesis is a clinical-stage cell therapy company that uses a patient's own lymph nodes as bioreactors to grow functioning ectopic organs. Its allogeneic cell therapies target diseases including end stage liver disease, end stage renal disease, Type 1 diabetes, and aging of the thymus.

1 investor

LymphaTouch is a Finnish health technology company that manufactures a medical device combining negative pressure and mechanical vibration for manual therapy applications including edema management, soft tissue mobilization, scar therapy, and pain management.

1 investor

Lync Bio develops fourth-generation SMART ADC (antibody-drug conjugate) technology for oncology, leveraging proprietary dual-target conjugate design and payload engineering to improve tumor coverage, cellular response, and manufacturability.

1 investor

Lyra Therapeutics develops biocompatible mesh scaffolds for sustained drug delivery to the sinonasal passages, targeting treatment of chronic rhinosinusitis. The company's proprietary platform uses bioabsorbable polymers and engineered matrices to deliver medication over up to six months with a single administration.

1 investor

Lyrica is a pharmaceutical product used to manage fibromyalgia, a chronic condition characterized by widespread pain and fatigue. The page provides patient education about fibromyalgia symptoms and treatment options including medication, self-care, and exercise.

1 investor

M20 Genomics develops single-cell and spatial transcriptome sequencing technologies for life science research, drug discovery, and disease diagnosis applications. The company offers proprietary VITA and NATA product lines based on its M20 Seq and M20 Spatial technologies.

1 investor